Anti-IFITM1, Polyclonal [IFITM1]
Invented at Cancer Research Horizons
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151497 |
| Applications | WB |
| Antigen/Gene or Protein Targets | Interferon-induced transmembrane protein 1 |
| Reactivity | Human |
| Relevance | Analyses of gene expression of IFN-inducible transmembrane protein (IFITM) levels revealed high levels of expression in early and late intestinal neoplasm in both mice and humans. IFITM gene expression is rapidly induced after activation of the -catenin signalling and expression is significantly up-regulated specifically in colorectal tumors and thus may be a useful diagnostic tool in these tumors. IFITM1 will recognise all 3 isoforms of IFITMs ( IFITM1, IFITM2 and IFITM3). |
| Host | Rabbit |
| Immunogen | HKEEHEVAVLGAPPSTILPRST |
| Notes | Suggested dilution: 1:2000. The antibody cross reacts with human IFITM2 and IFITM3 |
| Research Area | Cancer, Cell Signaling & Signal Transduction, Immunology, Stem Cell Biology |
References: 2 entries
Singh et al. 2011. J Virol. 85(1):208-16. PMID: 20980524.
Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Europe PMC ID: 20980524
Add a reference
References: 2 entries
Singh et al. 2011. J Virol. 85(1):208-16. PMID: 20980524.
Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Add a reference
